Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Login
Link opens in a new tab
Search content at the UWA Profiles and Research Repository
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press/Media
Units
Equipment
Impacts
Refractory facial cutaneous leishmaniasis in a child
David Foley
,
Tim Ford
,
Anita Campbell
, Aleisha Anderson
, Briony J. Hazelton
,
Daniel Yeoh
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Refractory facial cutaneous leishmaniasis in a child'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Fluconazole
100%
Leishmaniasis
100%
Cutaneous Leishmaniasis
100%
Anaphylaxis
50%
Drug Megadose
50%
Venous Ulcer
50%
Immunocompromised Patient
50%
Desensitization
50%
Pediatrics Patient
50%
Ulcer Healing
50%
Granulocyte Macrophage Colony Stimulating Factor
50%
Allopurinol
50%
Biopsy Technique
50%
Amphotericin
50%
Paromomycin
50%
Sodium Stibogluconate
50%
Photochemotherapy
50%
Oral
50%
Side Effect
50%
Pharmacology, Toxicology and Pharmaceutical Science
Miltefosine
100%
Skin Leishmaniasis
100%
Fluconazole
100%
Leishmaniasis
100%
Desensitization
50%
Photodynamic Therapy
50%
Ulcer
50%
Granulocyte Macrophage Colony Stimulating Factor
50%
Allopurinol
50%
Immunocompromised Patient
50%
Ulcer Healing
50%
Paromomycin
50%
Sodium Stibogluconate
50%
Anaphylaxis
50%
Amphotericin
50%
Side Effect
50%
Immunology and Microbiology
Leishmaniasis
100%
Cutaneous Leishmaniasis
100%
Immunocompromised Patient
50%
Face
50%
Drug Megadose
50%
Granulocyte Macrophage Colony-Stimulating Factor
50%
Photodynamics
50%
Sodium Stibogluconate
50%
Anaphylaxis
50%
Allopurinol
50%